Pharmaceutical Pricing and Reimbursement in IndiaDecision ResourcesSeptember 25, 2009 38 Pages - SKU: DECR2444588 |
| Countries covered: India Introduction Faced with a dramatic slowdown in sales in mature pharmaceutical markets, multinational pharmaceutical companies are looking to substantially increase their sales in India and other emerging markets. The Indian market is growing by more than 10% per year, but foreign companies will need to overcome signifi cant obstacles to succeed in a market currently dominated by domestic manufacturers. Questions Answered in This Report
|
More India Pricing Reports
Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure by
GBI Research
Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure Summary GBI Research, the leading business ...
The Outlook for Pharmaceuticals in Brazil, Russia, India & China (pdf/xls) by
Espicom Healthcare Intelligence
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist ...
BRIC: Pricing, Reimbursment, and Regulatory Update by
Datamonitor
Datamonitor’s report BRIC: Pricing, Reimbursement, and Regulatory Update provides an update of changes to pricing, reimbursement and regulation in Brazil, Russia, India and China during ...
BRIC: Pricing, Reimbursement, and Regulatory Update by
Datamonitor
Overview of healthcare expenditure, healthcare systems, drug regulation, healthcare reforms, drug pricing and reimbursement, and intellectual property environments across multiple markets. Countries analyzed include: Brazil, ...
See all reports like this >>
More India Reports
D&B Country RiskLine Report: India by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: India by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report India January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
India: Country Profile by
MarketLine
INTRODUCTION This report provides a detailed analysis on India, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 India Industry & Market Outlook report by
Barnes Reports
The 2007 India Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in India and 500+ minor industries ...
See all reports like this >>
Related Markets
- Insurance & Managed Care
- General Insurance & Managed Care
- Pharmaceuticals
- Generics Drugs
- Regulation & Policy
- Prescription Drugs
- Pricing
Pricing Reports
- Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure
- The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
- Pharmaceutical Pricing Strategies – Changing Approaches to Meet Challenging Times

